These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 9449640

  • 1. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
    Osuga Y, Liang SG, Dallas JS, Wang C, Hsueh AJ.
    Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S, Ban T, Akamizu T, Kohn LD.
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [Abstract] [Full Text] [Related]

  • 4. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T, Moriyama K, Miura M, Saijo M, Matsuda F, Nakao K.
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [Abstract] [Full Text] [Related]

  • 5. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, Kohn LD.
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [Abstract] [Full Text] [Related]

  • 6. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
    Endo T, Haraguchi K, Ohmori M, Ikeda M, Ohta K, Onaya T.
    Biochem Biophys Res Commun; 1991 Sep 30; 179(3):1543-7. PubMed ID: 1656957
    [Abstract] [Full Text] [Related]

  • 7. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N, Tuppal R, Hawe BS, Briones-Urbina R, Farid NR.
    J Cell Biochem; 1986 Sep 30; 31(2):107-20. PubMed ID: 2426288
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM, Zonefrati R, Toccafondi R, Valente WA, Kohn LD.
    J Clin Endocrinol Metab; 1986 Feb 30; 62(2):357-67. PubMed ID: 2416769
    [Abstract] [Full Text] [Related]

  • 11. Identification of the peptides that inhibit the stimulation of thyrotropin receptor by Graves' immunoglobulin G from peptide libraries.
    Park JY, Kim IJ, Lee MH, Seo JK, Suh PG, Cho BY, Ryu SH, Chae CB.
    Endocrinology; 1997 Feb 30; 138(2):617-26. PubMed ID: 9002995
    [Abstract] [Full Text] [Related]

  • 12. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P, Chiovato L, Fiore E, Mammoli C, Rocchi R, Pinchera A.
    Acta Med Austriaca; 1996 Feb 30; 23(1-2):52-6. PubMed ID: 8767515
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. IgG thyrotrophin receptor antibody activity in Graves' disease; a study of TSH agonist and antagonist activities by isoelectric focusing.
    Creagh FM, Howells RD, Williams S, Didcote S, Hashim FA, Petersen VB, Rees Smith B.
    Clin Endocrinol (Oxf); 1986 Jan 30; 24(1):79-88. PubMed ID: 3011318
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS.
    Endocrinology; 1996 Aug 30; 137(8):3329-39. PubMed ID: 8754759
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
    Hidaka A, Okajima F, Ban T, Kosugi S, Kondo Y, Kohn LD.
    J Clin Endocrinol Metab; 1993 Nov 30; 77(5):1164-9. PubMed ID: 8077307
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.